Concepedia

Yoko Kayukawa

YK

Statistics

Publications

6

Citations

413

H-Index

6

Active since

2017

Affiliations

Chugai Pharma (United States)(Current)

Yoko Kayukawa is an author at Chugai Pharma (United States) specializing in bispecific antibodies, cd3-directed bispecific antibodies, and immunology.

ORCID

Publications per year

2017–2024

6

Publications

6

An anti–glypican 3/CD3 bispecific T cell–redirecting antibody for treatment of solid tumors

Takahiro Ishiguro, Yuji Sano, Shunichiro Komatsu et al. · Science Translational Medicine · 2017 · 203 citations

, , +15

A long-acting anti–IL-8 antibody improves inflammation and fibrosis in endometriosis

Ayako Nishimoto, Izumi Sato, Kiyotaka Nakano et al. · Science Translational Medicine · 2023 · 105 citations

, , +11

Engineering a bispecific antibody with a common light chain: Identification and optimization of an anti-CD3 epsilon and anti-GPC3 bispecific antibody, ERY974

Hirotake Shiraiwa, Atsushi Narita, Mika Kamata‐Sakurai et al. · Methods · 2018 · 52 citations

, , +17

Engineering CD3/CD137 Dual Specificity into a DLL3-Targeted T-Cell Engager Enhances T-Cell Infiltration and Efficacy against Small-Cell Lung Cancer

Hirofumi Mikami, Shu Feng, Yutaka Matsuda et al. · Cancer Immunology Research · 2024 · 24 citations · Full text

, , +17

Combination of T cell-redirecting bispecific antibody ERY974 and chemotherapy reciprocally enhances efficacy against non-inflamed tumours

Yuji Sano, Yumiko Azuma, Toshiaki Tsunenari et al. · Nature Communications · 2022 · 19 citations · Full text

, , +17

1–5 of 6